Daniel Arias
Stock Analyst at Stifel
(5.00)
# 8
Out of 5,115 analysts
165
Total ratings
60.42%
Success rate
142.72%
Average return
Main Sectors:
Stocks Rated by Daniel Arias
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ILMN Illumina | Maintains: Buy | $135 → $155 | $144.81 | +7.04% | 17 | Jan 20, 2026 | |
| TMO Thermo Fisher Scientific | Maintains: Buy | $583 → $700 | $578.61 | +20.98% | 17 | Jan 9, 2026 | |
| GH Guardant Health | Maintains: Buy | $100 → $120 | $114.04 | +5.23% | 5 | Jan 9, 2026 | |
| BLLN BillionToOne | Initiates: Buy | $145 | $82.51 | +75.74% | 1 | Dec 1, 2025 | |
| EXAS Exact Sciences | Downgrades: Hold | $80 → $105 | $102.34 | +2.60% | 8 | Nov 28, 2025 | |
| MTD Mettler-Toledo International | Maintains: Buy | $1,450 → $1,600 | $1,373.24 | +16.51% | 8 | Nov 10, 2025 | |
| BRKR Bruker | Maintains: Hold | $48 → $40 | $44.29 | -9.69% | 9 | Aug 5, 2025 | |
| AVTR Avantor | Maintains: Hold | $14 → $12 | $10.92 | +9.89% | 10 | Aug 4, 2025 | |
| RVTY Revvity | Maintains: Hold | $120 → $110 | $108.80 | +1.10% | 2 | Jul 29, 2025 | |
| TECH Bio-Techne | Maintains: Hold | $75 → $60 | $64.09 | -6.38% | 11 | May 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $260 | $218.89 | +18.78% | 10 | Mar 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $11 → $9 | $0.91 | +892.50% | 2 | Mar 12, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $21 → $18 | $20.20 | -10.89% | 6 | Feb 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $17 → $6 | $6.31 | -4.91% | 2 | Nov 13, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | $45 → $65 | $59.82 | +8.66% | 2 | Nov 11, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $332 → $360 | $370.72 | -2.89% | 16 | Nov 4, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $163 → $151 | $133.85 | +12.81% | 20 | May 30, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $54 → $44 | $53.67 | -17.76% | 4 | May 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $11 → $10 | $3.36 | +197.62% | 2 | Feb 23, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $165 → $207 | $149.37 | +38.58% | 9 | Feb 22, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $9 → $5 | $1.24 | +303.23% | 2 | Aug 14, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $28 → $10 | $2.99 | +234.45% | 2 | May 31, 2022 |
Illumina
Jan 20, 2026
Maintains: Buy
Price Target: $135 → $155
Current: $144.81
Upside: +7.04%
Thermo Fisher Scientific
Jan 9, 2026
Maintains: Buy
Price Target: $583 → $700
Current: $578.61
Upside: +20.98%
Guardant Health
Jan 9, 2026
Maintains: Buy
Price Target: $100 → $120
Current: $114.04
Upside: +5.23%
BillionToOne
Dec 1, 2025
Initiates: Buy
Price Target: $145
Current: $82.51
Upside: +75.74%
Exact Sciences
Nov 28, 2025
Downgrades: Hold
Price Target: $80 → $105
Current: $102.34
Upside: +2.60%
Mettler-Toledo International
Nov 10, 2025
Maintains: Buy
Price Target: $1,450 → $1,600
Current: $1,373.24
Upside: +16.51%
Bruker
Aug 5, 2025
Maintains: Hold
Price Target: $48 → $40
Current: $44.29
Upside: -9.69%
Avantor
Aug 4, 2025
Maintains: Hold
Price Target: $14 → $12
Current: $10.92
Upside: +9.89%
Revvity
Jul 29, 2025
Maintains: Hold
Price Target: $120 → $110
Current: $108.80
Upside: +1.10%
Bio-Techne
May 8, 2025
Maintains: Hold
Price Target: $75 → $60
Current: $64.09
Upside: -6.38%
Mar 14, 2025
Upgrades: Buy
Price Target: $260
Current: $218.89
Upside: +18.78%
Mar 12, 2025
Maintains: Buy
Price Target: $11 → $9
Current: $0.91
Upside: +892.50%
Feb 13, 2025
Maintains: Buy
Price Target: $21 → $18
Current: $20.20
Upside: -10.89%
Nov 13, 2024
Maintains: Buy
Price Target: $17 → $6
Current: $6.31
Upside: -4.91%
Nov 11, 2024
Downgrades: Hold
Price Target: $45 → $65
Current: $59.82
Upside: +8.66%
Nov 4, 2024
Maintains: Hold
Price Target: $332 → $360
Current: $370.72
Upside: -2.89%
May 30, 2024
Maintains: Buy
Price Target: $163 → $151
Current: $133.85
Upside: +12.81%
May 1, 2024
Maintains: Hold
Price Target: $54 → $44
Current: $53.67
Upside: -17.76%
Feb 23, 2024
Maintains: Buy
Price Target: $11 → $10
Current: $3.36
Upside: +197.62%
Feb 22, 2024
Maintains: Buy
Price Target: $165 → $207
Current: $149.37
Upside: +38.58%
Aug 14, 2023
Maintains: Buy
Price Target: $9 → $5
Current: $1.24
Upside: +303.23%
May 31, 2022
Maintains: Hold
Price Target: $28 → $10
Current: $2.99
Upside: +234.45%